About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Identifying Factors Underlying the Discontinuation of Triptans

NCT00890357·3 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Mayo Clinic

With

Merck Sharp & Dohme LLC

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Episodic Migraine or Chronic Migraine
Have used a triptan medication in the prior 3 months
Have used triptan medications for at least 1 year
Episodic Migraine or Chronic Migraine
Used any triptan medication in the last 2 years
Have not used a triptan medication in the last 6 months

The record

StatusCompleted

PhaseNo phase

Taking part292

StartedAug 2009

UpdatedMar 29, 2013

Conditions

Migraine Medication Adherence

Where3

University of South Florida College of Medicine
Tampa, Florida, United States
Washington University School of Medicine
St Louis, Missouri, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States

Clareo Health | Identifying Factors Underlying the Discontinuation of Triptans